Akanda Corp. (AKAN) 10-Year Financial Performance & Capital Metrics

AKAN • • Industrial / General

HealthcareSpecialty & Generic PharmaCannabis & Hemp ProductsMedical Cannabis Producers

AboutAkanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.Show more

Revenue $837K -61.3%
EBITDA -$4M +26.5%
Net Income -$4M +87.3%
EPS (Diluted) -3.93 +93.5%
Gross Margin 24.91% +382.7%
EBITDA Margin -506.95% -89.9%
Operating Margin -523.8% -12.6%
Net Margin -489.57% +67.2%
ROE -1830.03% -554.1%
ROIC -748.9% -1422.8%
Debt/Equity 0.08
Interest Coverage -43.78 -11.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Trading at only 0.3x book value

✗Weaknesses

✗Negative free cash flow
✗Shares diluted 96.6% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y172.32%

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-

EPS CAGR

10Y-

5Y-

3Y-

TTM-

ROCE

10Y Avg-200.57%

5Y Avg-200.57%

3Y Avg-168.59%

Latest-297.64%

Peer Comparison

Medical Cannabis Producers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
ACBAurora Cannabis Inc.	239.88M	4.24	148.77	27.01%	7.68%	4.54%	0.17
IXHLIncannex Healthcare Limited	132.26M	0.38	-0.28	378.7%	-1671.96%	-466.4%	0.02
TLRYTilray Brands, Inc.	1.13B	9.71	-0.29	4.84%	-252.55%	-136.55%	0.22
IMCCIM Cannabis Corp.	7.08M	1.35	-0.30	10.71%	-8.96%	-109.13%	5.73
AKANAkanda Corp.	190.81K	1.31	-0.33	-61.27%	-12.14%	-8.5%	0.08
INCRInterCure Ltd.	52M	0.95	-0.67	-32.82%	-28.38%	-17.05%	0.53
FLGCFlora Growth Corp.	6.84M	6.54	-5.03	-21.78%	-32.14%	-24.58%	1.09

Profit & Loss

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.06K	41.43K	2.62M	2.16M	836.66K
Revenue Growth %	-	19.09%	62.23%	-0.18%	-0.61%
Cost of Goods Sold+	1.81K	756.16K	649.88K	2.05M	628.28K
COGS % of Revenue	0.88%	18.25%	0.25%	0.95%	0.75%
Gross Profit+	253	-714.73K	3.27M	111.45K	208.38K
Gross Margin %	0.12%	-17.25%	1.25%	0.05%	0.25%
Gross Profit Growth %	-	-2826%	5.57%	-0.97%	0.87%
Operating Expenses+	1.67M	6.12M	22.15M	10.16M	4.59M
OpEx % of Revenue	808%	147.69%	8.45%	4.7%	5.49%
Selling, General & Admin	1.36M	5.81M	19.85M	5.88M	4.45M
SG&A % of Revenue	658.97%	140.23%	7.58%	2.72%	5.32%
Research & Development	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-
Other Operating Expenses	307.3K	309.02K	2.3M	4.28M	141.05K
Operating Income+	-1.67M	-2.57M	-20.18M	-10.05M	-4.38M
Operating Margin %	-807.87%	-62.03%	-7.7%	-4.65%	-5.24%
Operating Income Growth %	-	-0.54%	-6.85%	0.5%	0.56%
EBITDA+	-1.42M	-2.26M	-16.58M	-5.77M	-4.24M
EBITDA Margin %	-687.24%	-54.58%	-6.33%	-2.67%	-5.07%
EBITDA Growth %	-	-0.6%	-6.33%	0.65%	0.26%
D&A (Non-Cash Add-back)	248.74K	309.02K	3.6M	4.28M	141.05K
EBIT	-1.66M	-2.46M	-8.12M	-32.02M	-3.17M
Net Interest Income+	-634.97K	-10.42K	-114.44K	-255.62K	-93.61K
Interest Income	10.19K	90	886	39	6.49K
Interest Expense	645.16K	10.51K	115.32K	255.66K	100.11K
Other Income/Expense	-634.87K	96.45K	11.94M	-22.22M	1.11M
Pretax Income+	-2.3M	-2.47M	-8.24M	-32.28M	-3.27M
Pretax Margin %	-1115.7%	-59.71%	-3.14%	-14.94%	-3.91%
Income Tax+	0	0	0	0	0
Effective Tax Rate %	1%	3.29%	1.42%	1%	1.25%
Net Income+	-2.3M	-8.13M	-11.66M	-32.28M	-4.1M
Net Margin %	-1115.7%	-196.26%	-4.45%	-14.94%	-4.9%
Net Income Growth %	-	-2.53%	-0.43%	-1.77%	0.87%
Net Income (Continuing)	-2.3M	-2.47M	-8.24M	-32.28M	-3.27M
Discontinued Operations	0	-5.66M	-3.42M	-28.56M	-827.62K
Minority Interest	0	0	0	0	0
EPS (Diluted)+	-40.77	-127.66	-841.40	-60.91	-3.93
EPS Growth %	-	-2.13%	-5.59%	0.93%	0.94%
EPS (Basic)	-40.77	-127.66	4.59	-60.91	-3.93
Diluted Shares Outstanding	72.26K	72.26K	86.59K	529.92K	1.04M
Basic Shares Outstanding	72.26K	72.26K	86.59K	529.92K	1.04M
Dividend Payout Ratio	-	-	-	-	-

Balance Sheet

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	127.6K	3.98M	3.82M	1.81M	5.06M
Cash & Short-Term Investments	13.5K	3.5M	492.49K	82.82K	3.84M
Cash Only	13.5K	3.5M	228.79K	82.82K	3.84M
Short-Term Investments	0	0	263.69K	0	0
Accounts Receivable	0	242.36K	1.24M	284.51K	822.07K
Days Sales Outstanding	-	2.14K	172.16	48.08	358.63
Inventory	611	0	1.87M	1.29M	0
Days Inventory Outstanding	123.28	-	1.05K	229.29	-
Other Current Assets	0	0	27.01K	11.06K	3.22K
Total Non-Current Assets+	4.15M	4.07M	35.18M	7.03M	2.86M
Property, Plant & Equipment	3.83M	3.81M	12.48M	2.64M	2.34M
Fixed Asset Turnover	0.00x	0.01x	0.21x	0.82x	0.36x
Goodwill	0	0	0	0	0
Intangible Assets	321.41K	259.1K	22.21M	3.8M	15.83K
Long-Term Investments	0	0	0	593.23K	503.49K
Other Non-Current Assets	0	0	967.18K	0	0
Total Assets+	4.27M	8.05M	39M	8.84M	7.91M
Asset Turnover	0.00x	0.01x	0.07x	0.24x	0.11x
Asset Growth %	-	0.88%	3.85%	-0.77%	-0.1%
Total Current Liabilities+	2.73M	8.27M	9.35M	10.17M	3.64M
Accounts Payable	183.9K	680.33K	7.14M	6.01M	2.98M
Days Payables Outstanding	37.1K	328.4	4.01K	1.07K	1.73K
Short-Term Debt	2.26M	7.15M	936.79K	1.37M	352.81K
Deferred Revenue (Current)	0	0	0	0	0
Other Current Liabilities	0	0	377.46K	1.42M	0
Current Ratio	0.05x	0.48x	0.41x	0.18x	1.39x
Quick Ratio	0.05x	0.48x	0.21x	0.05x	1.39x
Cash Conversion Cycle	-	-	-2.79K	-794.25	-
Total Non-Current Liabilities+	6.58M	1.98M	2.75M	2.5M	0
Long-Term Debt	3.98M	0	2.63M	2.5M	0
Capital Lease Obligations	2.6M	1.98M	116.76K	0	0
Deferred Tax Liabilities	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0
Total Liabilities	9.31M	10.25M	12.1M	12.67M	3.64M
Total Debt+	9.12M	9.57M	3.9M	4M	352.81K
Net Debt	9.11M	6.07M	3.67M	3.92M	-3.49M
Debt / Equity	-	-	0.14x	-	0.08x
Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-
Interest Coverage	-2.58x	-244.57x	-174.95x	-39.32x	-43.78x
Total Equity+	-5.03M	-2.2M	26.9M	-3.83M	4.28M
Equity Growth %	-	0.56%	13.22%	-1.14%	2.12%
Book Value per Share	-69.64	-30.47	310.65	-7.23	4.10
Total Shareholders' Equity	-5.03M	-2.2M	26.9M	-3.83M	4.28M
Common Stock	1.64K	7.26M	49.43M	51.02M	63.32M
Retained Earnings	-5.16M	-13.29M	-21.09M	-53.36M	-57.46M
Treasury Stock	0	0	0	0	0
Accumulated OCI	129.11K	3.84M	-1.45M	-1.49M	-1.58M
Minority Interest	0	0	0	0	0

Cash Flow

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.35M	-6.56M	-11.47M	-1.5M	-3.98M
Operating CF Margin %	-655.9%	-158.26%	-4.38%	-0.69%	-4.76%
Operating CF Growth %	-	-3.85%	-0.75%	0.87%	-1.65%
Net Income	-2.3M	-8.13M	-11.66M	-32.28M	-4.1M
Depreciation & Amortization	248.74K	309.02K	3.76M	4.28M	141.05K
Stock-Based Compensation	0	0	559.23K	0	0
Deferred Taxes	0	0	0	0	0
Other Non-Cash Items	668.91K	1.85M	-6.32M	23.34M	924.92K
Working Capital Changes	30.45K	-587.5K	2.18M	3.15M	-950.31K
Change in Receivables	0	-242.36K	-591.07K	973.38K	-254.68K
Change in Inventory	-611	-712.52K	501.71K	482.72K	366.21K
Change in Payables	140.9K	242.36K	2.92M	1.54M	-733.36K
Cash from Investing+	-432.2K	-576.47K	-4.22M	24.89K	-1.02M
Capital Expenditures	-439.14K	-576.47K	-310.95K	-1.5K	-2.1M
CapEx % of Revenue	212.97%	13.91%	0.12%	0%	2.51%
Acquisitions	-	-	-	-	-
Investments	-	-	-	-	-
Other Investing	6.93K	0	-739.95K	26.39K	-366.6K
Cash from Financing+	1.03M	11.24M	14.14M	1.49M	8.99M
Debt Issued (Net)	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-
Dividends Paid	0	0	0	0	0
Share Repurchases	-	-	-	-	-
Other Financing	0	0	0	1.57M	-1.43M
Net Change in Cash	-	-	-	-	-
Free Cash Flow+	-1.79M	-7.13M	-11.78M	-1.5M	-6.08M
FCF Margin %	-868.87%	-172.18%	-4.5%	-0.7%	-7.27%
FCF Growth %	-	-2.98%	-0.65%	0.87%	-3.05%
FCF per Share	-24.79	-98.72	-136.04	-2.83	-5.83
FCF Conversion (FCF/Net Income)	0.59x	0.81x	0.98x	0.05x	0.97x
Interest Paid	0	0	0	0	0
Taxes Paid	0	0	0	0	0

Key Ratios

Metric	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-94.4%	-279.79%	-1830.03%
Return on Invested Capital (ROIC)	-	-48.51%	-87.87%	-49.18%	-748.9%
Gross Margin	12.27%	-1725.1%	124.81%	5.16%	24.91%
Net Margin	-111569.88%	-19625.88%	-445%	-1494.18%	-489.57%
Debt / Equity	-	-	0.14x	-	0.08x
Interest Coverage	-2.58x	-244.57x	-174.95x	-39.32x	-43.78x
FCF Conversion	0.59x	0.81x	0.98x	0.05x	0.97x
Revenue Growth	-	1909.26%	6223%	-17.55%	-61.27%

Frequently Asked Questions

Growth & Financials

Akanda Corp. (AKAN) reported $3.0M in revenue for fiscal year 2024. This represents a 145231% increase from $0.0M in 2020.

Akanda Corp. (AKAN) saw revenue decline by 61.3% over the past year.

Akanda Corp. (AKAN) reported a net loss of $36.4M for fiscal year 2024.

Dividend & Returns

Akanda Corp. (AKAN) has a return on equity (ROE) of -1830.0%. Negative ROE indicates the company is unprofitable.

Akanda Corp. (AKAN) had negative free cash flow of $7.6M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener